Linee Guida AIOM (Associazione Italiana di Oncologia Medica)
Linee Guida AIOM (Associazione Italiana di Oncologia Medica) Linee Guida AIOM (Associazione Italiana di Oncologia Medica)
Trial). N Engl Med 2006Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiation after surgery compared withsurgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl Med2001;345(10):725-730.Fiorica F, Cartei F, Enea M, Licata A, Cabibbo G, Carau B, Liboni A, Ursino S, Cammà C The impact ofradiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev.2007 Dec;33(8):729-40.Valentini V, Cellini F, Mattiucci GC, Balducci M, D’Agostino G, D’Angelo E, Dinapoli N, Nicolotti C,Valentini C, La Torre G, A meta-analysis to assess the impact of radiotherapy on the survival of patients withgastric cancer. Radiotherapy and Oncology, Vol 88, Supp 1 (abs), 2008Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy inAdvanced gastric cancer: a systematic review and meta-analysis based on aggregate data. JClin Oncol 24: 2903-2909; 2006.Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. CritRev Oncol/Hematol 54: 209-241; 2005.Janunger KG, Hafstrom L, Nygren P, Glimelius B, SBU-Group, Swedish Council ofTechnology Assessment in Health Care. A systematic overview of chemotherapy effects ingastric cancer. Acta Oncol 40: 309-326; 2001.Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J,Norman AR;Capecitabine and oxaliplatin for advanced esophagogastric cancer.N Engl J Med. 358:36-46, 2008.Trumper M, Ross PJ, Cunningham D, Norman AR, Hawkins R, Seymour M, Harper P, IvesonT, Nicolson M, Hickish T. Efficacy and tolerability of chemotherapy in elderly patients withadvanced oesophago-gastric cancer: A pooled analysis of three clinical trials. Eur J Cancer 42:827-834; 2006.Moertel CG, ChildsDS Jr, Reitemeier RJ Combined 5-Fluorouracil and supervoltage radiation therapy oflocally unresectable gastrointestinal cancer. Lance 2:865-867, 1969Schein P, Novak J (for GITSG) Combined modality therapy (XRT-Chemo) versus chemotehrapy alone forlocally unresectable gastric cancer. Cancer Chemother Pharmacol 49:1771-5, 1990Gunderson L, Hoskins B, Cohen AM. Combined modality treatment of gastric cancer. Int J Radiat OncolBiol Phys 9:965-71, 1983
- Page 1 and 2: Neoplasie dellostomacoAggiornate a
- Page 3 and 4: Referee AIOM:A. FalconeReferee AIRO
- Page 5 and 6: STADIO II T1 N2 M0T2 N1 M0T3 N0 M0S
- Page 7 and 8: necessaria per poter classificare u
- Page 9 and 10: La maggioranza degli studi randomiz
- Page 11 and 12: I dati dello studio REAL-2 suggeris
- Page 13: BibliografiaDicken BJ, Bigam DL, Ca
Trial). N Engl Med 2006Macdonald JS, Smalley SR, Benedetti J et al. Chemora<strong>di</strong>ation after surgery compared withsurgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl Med2001;345(10):725-730.Fiorica F, Cartei F, Enea M, Licata A, Cabibbo G, Carau B, Liboni A, Ursino S, Cammà C The impact ofra<strong>di</strong>otherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev.2007 Dec;33(8):729-40.Valentini V, Cellini F, Mattiucci GC, Balducci M, D’Agostino G, D’Angelo E, Dinapoli N, Nicolotti C,Valentini C, La Torre G, A meta-analysis to assess the impact of ra<strong>di</strong>otherapy on the survival of patients withgastric cancer. Ra<strong>di</strong>otherapy and Oncology, Vol 88, Supp 1 (abs), 2008Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy inAdvanced gastric cancer: a systematic review and meta-analysis based on aggregate data. JClin Oncol 24: 2903-2909; 2006.Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. CritRev Oncol/Hematol 54: 209-241; 2005.Janunger KG, Hafstrom L, Nygren P, Glimelius B, SBU-Group, Swe<strong>di</strong>sh Council ofTechnology Assessment in Health Care. A systematic overview of chemotherapy effects ingastric cancer. Acta Oncol 40: 309-326; 2001.Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J,Norman AR;Capecitabine and oxaliplatin for advanced esophagogastric cancer.N Engl J Med. 358:36-46, 2008.Trumper M, Ross PJ, Cunningham D, Norman AR, Hawkins R, Seymour M, Harper P, IvesonT, Nicolson M, Hickish T. Efficacy and tolerability of chemotherapy in elderly patients withadvanced oesophago-gastric cancer: A pooled analysis of three clinical trials. Eur J Cancer 42:827-834; 2006.Moertel CG, ChildsDS Jr, Reitemeier RJ Combined 5-Fluorouracil and supervoltage ra<strong>di</strong>ation therapy oflocally unresectable gastrointestinal cancer. Lance 2:865-867, 1969Schein P, Novak J (for GITSG) Combined modality therapy (XRT-Chemo) versus chemotehrapy alone forlocally unresectable gastric cancer. Cancer Chemother Pharmacol 49:1771-5, 1990Gunderson L, Hoskins B, Cohen AM. Combined modality treatment of gastric cancer. Int J Ra<strong>di</strong>at OncolBiol Phys 9:965-71, 1983